Home  /  News Of Farmacy  /  Núm: 2 Par: PP (2015)  /  Article
ARTICLE
TITLE

The study of a possible general toxical action of 5,7-dihydro-1H-pyrrolo[2,3-d]pyrimidine derivatives

SUMMARY

It has been experimentally proven that with the intraperitoneal way of introduction of Dezapur the maximum tolerated dose for mice is 2000 mg/kg, the least toxic dose – 1000 mg/kg, the median lethal dose – 3000 mg/kg. When the dose of 3500 mg/kg was introduced to rats one animal died; in the dose of 5000 mg/kg there was 100% death of animals, the median lethal dose was 4500 mg/kg of the animal’s weight. In intragastric introduction the maximum dose of Dezapur for mice was 6000 mg/ kg, for rats it was 11000 mg/kg; by the end of the observation period all animals were alive and alert. According to K.K.Sydorov classification the derivative with the code of KMS-211 (“Dezapur”) has been proven to belong to practically nontoxic substances (the VI class of toxicity).

 Articles related

N. ?. Vakhnina    

THE EXPERIMENTAL STUDY OF THE ANALGESIC AND ANTIPYRETIC ACTIVITY OF THE NEW MALONIC ACID DERIVATIVES -MALDENN. ?. VakhninaNationalUniversityofPharmacy, Kharkiv      Introduction. The article is devoted to the study of analgesic and an... see more


Yu. O. Ovsjanykova, K. M. Sytnik, A. L. Shemchuk, A. L. Zagayko, V. P. Fylymonenko    

SYNTHESIS OF FUNCTIONAL DERIVATIVES OF 3-AMINO-2-R-7-(R'-PHENYL)-3H-THIENO[2,3-d]PYRIMIDINE-4-ONES AND STUDY OF THEIR ANTI-DIABETIC ACTIVITYOvsjanykova Yu.O., Sytnik K.M., Shemchuk L.A., Zagayko A.L., Fylymonenko V.P.National University of Pharmacy,... see more


A. O. Dobrova,A. S. Materiienko,O. S. Golovchenko,V. A. Georgiyants    

When taking the antibiotics of the tetracycline group together with food and drinks the components may decrease bioavailability, the effectiveness of the drug and change the kinetics of its release. A bright example is the interaction of doxycycline with... see more


V. Ye. Dobrova,K. O. Zupanets,K. L. Ratushna    

The study of risk is essential to the proper planning of clinical trials (CT). At the same time analysis of information concerning possible inconsistencies is done; it allows to develop a corresponding programme of actions, take steps to minimize them an... see more


O. V. Gerush,L. V. Iakovlieva,S. V. Spyrydonov,S. A. Grashchenkova    

A high prevalence of hepatobiliary system disorders among the population was the key factor for development of combined herbal medicinal products with the hepatoprotective action, namely Hepafisan capsules, Phytovenol capsules,Polyherbagastrin granules a... see more